>>Back
Roche runs short on Boniva after overestimating generic erosion
  • Publisher:
  • Publication:2012/8/20
Many companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught by surprise, however, by a lack thereof; leading to a shortage of the injectable version of its osteoporosis drug Boniva when demand outstripped its supply